Insufficient scRNA-seq data for expression of NME2P1 at single-cell level.
Insufficient scRNA-seq data for expression of NME2P1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 98% | 12.56 | 176 / 180 | 100% | 12.15 | 428 / 430 |
esophagus | 97% | 12.73 | 1404 / 1445 | 100% | 15.37 | 183 / 183 |
stomach | 97% | 10.33 | 349 / 359 | 94% | 12.32 | 269 / 286 |
skin | 99% | 15.42 | 1794 / 1809 | 92% | 6.04 | 433 / 472 |
intestine | 96% | 11.30 | 930 / 966 | 91% | 9.96 | 482 / 527 |
bladder | 100% | 15.38 | 21 / 21 | 78% | 4.45 | 392 / 504 |
lung | 98% | 13.69 | 564 / 578 | 77% | 5.26 | 894 / 1155 |
uterus | 98% | 13.81 | 166 / 170 | 74% | 3.99 | 339 / 459 |
prostate | 99% | 13.48 | 242 / 245 | 73% | 2.94 | 364 / 502 |
pancreas | 99% | 32.66 | 324 / 328 | 60% | 2.29 | 106 / 178 |
thymus | 96% | 11.19 | 630 / 653 | 50% | 1.87 | 300 / 605 |
breast | 100% | 15.16 | 457 / 459 | 46% | 2.23 | 509 / 1118 |
liver | 91% | 9.23 | 205 / 226 | 49% | 2.05 | 198 / 406 |
kidney | 90% | 10.67 | 80 / 89 | 38% | 1.60 | 342 / 901 |
brain | 77% | 5.83 | 2046 / 2642 | 45% | 4.78 | 319 / 705 |
adrenal gland | 94% | 10.56 | 243 / 258 | 22% | 0.77 | 51 / 230 |
eye | 0% | 0 | 0 / 0 | 100% | 7.71 | 80 / 80 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.85 | 1 / 1 |
blood vessel | 100% | 17.92 | 1329 / 1335 | 0% | 0 | 0 / 0 |
adipose | 99% | 13.59 | 1186 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 4.01 | 28 / 29 |
spleen | 93% | 9.45 | 225 / 241 | 0% | 0 | 0 / 0 |
muscle | 84% | 8.02 | 673 / 803 | 0% | 0 | 0 / 0 |
heart | 82% | 6.88 | 708 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 62% | 2.47 | 28 / 45 |
peripheral blood | 59% | 5.74 | 545 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006183 | Biological process | GTP biosynthetic process |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0006228 | Biological process | UTP biosynthetic process |
GO_0006241 | Biological process | CTP biosynthetic process |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005634 | Cellular component | nucleus |
GO_0004550 | Molecular function | nucleoside diphosphate kinase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | NME2P1 |
Protein name | Putative nucleoside diphosphate kinase (NDK) (NDP kinase) (EC 2.7.4.6) |
Synonyms | |
Description | FUNCTION: Major role in the synthesis of nucleoside triphosphates other than ATP. The ATP gamma phosphate is transferred to the NDP beta phosphate via a ping-pong mechanism, using a phosphorylated active-site intermediate (By similarity). . |
Accessions | O60361 |